Dental Implants for Tooth Loss

HS
Overseen ByHanae Saito
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: University of Maryland, Baltimore
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This prospective clinical study will compare early healing and implant stability between two Nobel Biocare dental implant systems, NobelReplace S-TiUltra and NobelReplace CC TiUnite. Approximately 30 implants will be randomly assigned to one of the two implant groups and followed for 12 weeks after placement. Implant stability will be assessed using resonance frequency analysis at implant placement and at approximately 2, 4, 6, 8, and 12 weeks. Clinical healing, radiographic findings, and other treatment-related outcomes will also be evaluated during the follow-up period.

Are You a Good Fit for This Trial?

This trial is for adults who need dental implants due to missing teeth. Participants should be healthy enough for oral surgery and able to attend follow-up visits. People with conditions that could affect healing or implant success may not be eligible.

Inclusion Criteria

I am 18 years old or older.
Provision of informed consent
Partially edentulous patients
See 4 more

Exclusion Criteria

I do not have any condition that would affect my bone healing or metabolism.
Previous history of failed implants
Heavy smoking (>10 cigarettes/day)
See 6 more

What Are the Treatments Tested in This Trial?

Interventions

  • NobelReplace S-TiUltra
  • NobelReplace TiUnite

Trial Overview

The study compares two types of dental implants, NobelReplace S-TiUltra and NobelReplace TiUnite, by randomly assigning patients to receive one type. Healing and stability are checked over a 12-week period after the implant is placed.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: S-TiUltraExperimental Treatment1 Intervention
Group II: TiUniteActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Maryland, Baltimore

Lead Sponsor

Trials
729
Recruited
540,000+